Financials data is unavailable for this security.
View more
Year on year VG Life Sciences Inc had revenues remain flat at 0.00, though the company grew net income from a loss of 7.42m to a smaller loss of 6.19m.
Gross margin | -- |
---|---|
Net profit margin | -- |
Operating margin | -- |
Return on assets | -384.41% |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in USDView more
In 2014, cash reserves at VG Life Sciences Inc fell by 679.90k. Cash Flow from Financing totalled 1.23m or -- of revenues. In addition the company used 1.91m for operations while cash from investing was breakeven.
Cash flow per share | -0.0071 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.0491 |
---|---|
Tangible book value per share | -0.0597 |
More ▼
Balance sheet in USDView more
Current ratio | 0.0074 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼